SIGNUP FOR
NEWSLETTER
TSX: HSM
NASDAQ: HSDT
Call us: +1 877-564-0008
About
Back
Overview
Meet Our Team
Advisory Board
Scientific Interests
Divisions
Back
Overview
Helius Medical
Back
The PoNS Device
Investor Relations
Back
Overview
Stock Info
Events
Back
Upcoming Events
Past Events
Code of Conduct
Corporate Documents
Committee Charters
SEC Filings
Financial Information
Back
2019
Back
Q2 2019
Q1 2019
2018
Back
Q4 2018
Q3 2018
Q2 2018
Q1 2018
2017
Back
Q4 2017
Q3 2017
Q2 2017
Q1 2017
2016
Back
Q3 2016
Q2 2016
Q1 2016
2015
Back
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Investor FAQ
Newsroom
Back
News Releases
Back
2021
2020
2019
2018
Archive
Back
2017
2016
2015
2014
In the News
Back
HMT Coverage
Related Science
Media Resources
Our Research
Back
Overview
Clinical Trials
Peer-Reviewed Publications
Words to Know
Research Partners
Contact
Back
Contact HMT
Subscribe Newsletter
Careers
Back
Home
Newsroom
News Releases
Menu
News Releases
2021
2020
2019
2018
Archive
2017
2016
2015
2014
In the News
HMT Coverage
Related Science
Media Resources
Stock Quote - HSM-T
*Delayed quote courtesy of Google.
Stock Quote - HSDT
*Delayed quote courtesy of Google.
2019 News
Filters
- Select Tag -
Clinical News
Corporate News
Filter
List of articles in category 2019 News
Title
Date
Independent Research Published Show Positive Results on Translingual Neurostimulation Plus Physical Therapy With Statistically Significant Improvement in Balance and Gait Scores and the Outcomes Were Sustained for 12 Weeks After Discontinuing Treatment
19 Dec, 2019
Helius Medical Technologies, Inc. Announces Pricing of Public Offering
22 Nov, 2019
Helius Medical Technologies, Inc. Announces Proposed Public Offering
21 Nov, 2019
Helius Medical Technologies, Inc. Announces Addition of P3 Health As New Authorized PoNS Treatment™ Clinic in Toronto, Canada
19 Nov, 2019
Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year 2019 Outlook
12 Nov, 2019
Helius Medical Technologies, Inc. Announces Update on US Regulatory Strategy Following Pre-Submission Meeting with FDA
24 Oct, 2019
Helius Medical Technologies to Release Third Quarter of Fiscal Year 2019 Financial Results on November 12, 2019
01 Oct, 2019
Helius Medical Technologies, Inc. Announces Addition of a New PoNS™ Clinic in Quebec City, Canada
13 Sep, 2019
Helius Medical Technologies, Inc. Provides a Business Update on Clinical Experience to Date in Canada
28 Aug, 2019
Helius Medical Technologies, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook
08 Aug, 2019
Helius Medical Technologies, Inc. Announces Results of Matters Submitted for Vote at 2019 Annual Meeting of Stockholders
12 Jul, 2019
Helius Medical Technologies to Release Second Quarter of Fiscal Year 2019 Financial Results on August 8, 2019
02 Jul, 2019
Helius Medical Technologies, Inc. Provides a Business Update on FDA Strategy
18 Jun, 2019
Helius Medical Technologies, Inc. Announces Scientific Publication Confirming Tongue Stimulation with PoNS™ Alters Brain Activity
11 Jun, 2019
Helius Medical Technologies to Present at the JMP Securities Life Sciences Conference
07 Jun, 2019
Helius Medical Technologies, Inc. Announces Addition of Three New PoNS™ Authorized Clinics in Canada
05 Jun, 2019
Helius Medical Technologies, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook
09 May, 2019
Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification and 510(k) Clearance of the PoNS™ Device
10 Apr, 2019
Helius Medical Technologies to Release First Quarter of Fiscal Year 2019 Financial Results on May 9, 2019
02 Apr, 2019
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Introduces Full Year 2019 Outlook
14 Mar, 2019
Helius Medical Technologies, Inc. to Present at Oppenheimer’s 29th Annual Healthcare Conference
06 Mar, 2019
Helius Medical Technologies, Inc. Announces First Patients in Canada Treated with Commercially Available PoNS™ Treatment
05 Mar, 2019
Helius Medical Technologies, Inc. Announces Company-Hosted Event at Medical Meeting in March
28 Feb, 2019
Uptick Newswire Hosts Helius Medical Technologies, Inc. on the Stock Day Podcast to Discuss the Company’s Clearance in Canada and Expansion into The United States and Europe
11 Feb, 2019
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 14, 2019
07 Feb, 2019
Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification and 510(k) Clearance of the PoNS™ Device
25 Jan, 2019
Helius Medical Technologies, Inc. Announces Fourth Partnership to Implement Clinical Experience Programs with PoNS™ Treatment in the United States
03 Jan, 2019
Helius Medical Technologies, Inc. Announces Third Collaboration to Implement Clinical Experience Programs with PoNS™ Treatment in the United States
03 Jan, 2019